KRas G12C inhibitors
US10125134B2 · kind B2 · utility
25Cited by
3References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 15, 2017 |
| Grant date | Nov 13, 2018 |
| Priority date | — |
| Expiry date | Nov 15, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.